Marapharm Ventures Inc. (“Marapharm” or the “Company”) is a publicly traded company, primarily investing in the medical and recreational cannabis space, with operations based in British Columbia, Canada.

Company Highlights

  • Purchased 7 acres of industrial property in Las Vegas, Nevada with buildings approved for three licenses for cannabis cultivation and processing
  • Closing on 13.6 acres of industrial property in Washington State, which is approved for marijuana cultivation, processing and a proposed cannabis campus.
  • Purchased two industrial properties in California, which are approved for marijuana cultivation and processing
  • Owns a cannabis delivery Service for medical marijuana deliveries in Desert Hot Springs  California
  • Owns Green Leaf Dispensary in Desert Hot Springs, California
  • Acquired, has control of or has applications in process for 11 licenses in the United States and Canada
  • Purchased 18 million shares and warrants of Veritas Pharma Inc., a public company to leverage synergy in research and development
  • Marapharm.tv is a company owned site which posts weekly market reports on Marapharm’s stock activity and news related to the cannabis industry
  • The company is considering retail opportunities to complement its cultivation and processing abilities. This will allow the control of the quality, marketing and messaging behind our products.

 

Detailed Corporate Overview

Through its wholly owned operating subsidiary Marapharm Inc., the Company has applied to Health Canada to become a licensed producer under the Access to Cannabis for Medical Purposes Regulations (ACMPR).  Marapharm’s initial facility, a proposed 22,000 sq ft state-of-the-art cultivation facility, will be constructed on an 11 acre leased site in Kelowna, British Columbia.

The Company’s growth strategy will be to build facilities or acquire licenses in the United States, determined by identifying opportunities in the market. The company has currently focused its attention on opportunities in Nevada, Washington and California. Land has been purchased and construction has begun, In the Apex Business Park in the City of North Las Vegas, Nevada. The company’s intention is to build cultivation and processing facilities in this location, which will utilize two medical cultivation licenses and one medical processing license. In Washington State, the Company has an opportunity to lease a facility to an I-502, tier 3 license holder. The licensee holds a production license for 30,000 sq ft and a processing license with unlimited potential. In California, we have purchased two industrial properties and own a delivery service for medical cannabis.

Marapharm has also purchased and is developing an all-natural hemp oil based cosmetic line called, Maragold, which will be ready for market within a few months. The products created by Maragold will be marketed online directly to end-users and will be sold individually or by subscription.

 

Market Opportunity

The Canadian market for legalized medical and recreational marijuana has been projected to conservatively exceed $12.7 billion. The market for medicinal use in Canada was estimated at $144 million in 2014 and expected to grow by 23% per year to $1.3 billion over the next 10 years.

Currently in the United States there are 29 states that have legalized medical marijuana and 8 states have legalized adult use recreational marijuana.  In 2016 in the United States alone, legal cannabis sales brought in 7.2 billion dollars and are projected to grow at a compound annual rate of 17%. By 2020 the legal market is projected to have a value of 24.5 Billion dollars.

 

Officers and Directors

Linda Sampson, President and CEO
Linda Sampson brings a dynamic energy, a wealth of talent, and a multi-layered business expertise to the Company. She is a business start-up professional, with a history of ground-up to successful ventures.  An accomplished sales professional, marketer, designer, developer, with international experience, she brings superior business branding skills and internal administrative talents to Marapharm.

 

Corey Klassen, VP of Corporate Development and Director
Corey Klassen has a strong financing background and more than 20 years of business development management experience for major Canadian financial institutions, mortgage brokerage firms and publicly traded companies. Corey is the owner of a successful mortgage brokerage and was recently recognized as one of the top 75 brokers in Canada by CMP Magazine.

As a director and advisor for various junior companies over the past several years, his financial background and expertise provides considerable experience with public companies where he has been instrumental in numerous capital raising ventures inclusive of medical marijuana companies.

 

Yari Nieken, Director and Audit Committee
Yari has a wide range of public company and capital market experience. He is the founder and president of Foremost Capital Inc., an exempt market dealer. He is a consultant for public companies with Paradigm Shift Consulting, has served on boards of several public companies and was an investment advisor at Union Securities and remains a registrant in good standing in British Columbia, Alberta and Ontario. Yari holds an MBA from the Sydney Graduate School of Management and a BA from the University of British Columbia.

 

Hanspaul Pannu, Chief Financial Officer
Mr. Pannu has worked in the Canadian small cap public company space for over 5 years providing financial reporting, corporate secretary, listing and general accounting support. He is currently the Chief Financial Officer of Appature Mobile Applications Inc., a blockchain technology and mobile application company and has held or currently holds a senior financial position with LED Medical Diagnostics Inc. (TSX-V: LMD), Aequus Pharmaceuticals Inc. (TSX-V:AQS, OTCQB:AQSZF), Veritas Pharma Inc.(CSE:VRT), Blok Technologies Inc.(CSE:BLK), and Sharc International Systems Inc. (CSE:SHARC). He is a Chartered Professional Accountant.

 

David Alexander, Director
Mr. Alexander is the Chief Financial Officer and Director of Veritas Pharma Inc. Mr. Alexander’s past achievements include his role as the CFO of Arakis Energy Corporation, an international oil and gas development company, where he managed the company’s growth from start-up to over a billion dollars in assets, leading to a listing on the NASDAQ market. Arakis was subsequently sold to Talisman Energy. He was also CFO of Nortran Pharmaceuticals, Inc., a University of British Columbia based pharmaceutical Research and Development Company engaged in the development and commercialization of cardiovascular therapies. While at Nortran, David helped secure initial and ongoing research financing. Nortran subsequently, became Cardiome Pharma Corp., a successful Vancouver BC based pharmaceutical company (Nasdaq: CRME). David is a Chartered Professional Accountant.

 

Brad Dixon, Director
Brad Dixon is a trial attorney with the Givens Pursley LLP litigation group.  Brad brings a broad range of trial and litigation experience representing clients in disputes involving complex commercial litigation, secured transactions, real estate, foreclosure, employment, insurance coverage, products liability, and bankruptcy trial practice. Brad was selected as one of America’s leading lawyers for business (Idaho) by Chambers USA and was listed among rising stars in civil litigation defence by Mountain States Super Lawyers

 

Management Advisory Group (MAG)

Ron Cannan
Ron Cannan is a business and community consultant with more than 30 years of experience in small business, marketing, government operations and public policy development at various levels of government. Ron was elected as a Member of Parliament of Kelowna in 2006,2008 and 2011. Ron also served a total of nine years on Kelowna City Council and as director for the Central Okanagan Regional District and the Central Okanagan Regional Hospital District.

Prior to entering politics, Ron was a self-employed retail business person in Alberta and British Columbia. He also had a successful career in sales and marketing for media companies and for enterprises such as Costco Wholesale and Coca-Cola and managed several automobile dealerships.

 

Business and Industry Advisors

Several business strategists, negotiators, deal facilitators, security lawyers and financial professionals consult with Marapharm Ventures Inc. throughout the sourcing, merger, acquisition and management processes of our business expansion and diversified ventures.

 

Operations Management Team

Kurt Keating, Director of Operations
Kurt Keating brings with him a dynamic skill set based on experience in multiple industries.Currently Kurt is an i-502 tier three license holder in Washington State and recently Kurt worked as an owner/operator of PhenoType Farmers LLC, a High Times Cannabis Cup winning, true living organic, medical cannabis company based in Washington State. Kurt is truly passionate about this industry, looking to grow the cleanest and highest quality product possible.

Previously, Kurt worked as a consultant for Slalom Consulting. He provided consultation for a wide array of companies and non-profit foundations, such as the Bill and Melinda Gates Foundation, Nintendo of America, Holland America Cruise Lines and Pacific Market International. He also has a long career as a Sr. Functional and Financial Analyst for Starbucks Coffee Company.

 

Randy Kolibaba – Security Professional Consultant
Randy Kolibaba is a results-driven senior executive having distinguished service in the Royal Canadian Mounted Police and the United Nations. He has had proven success promoting; efficiency, growth and profitability in diversified policing and protective services, combined with extensive international expertise. Noted for abilities in leadership, Threat/Risk assessment, Vulnerability analysis, Disaster Planning and Management, Major Crimes investigations, Project management, Strategic Planning, Workplace safety, Employee development and Change management, Diversified uniform and plain clothes background that includes general duty patrol and investigation, road safety and traffic law enforcement, Nationally recognized First Nations policing experience. Legally trained and appointed by the Federal Court of Canada as an adjudicator for the RCMP, extensive command experience at the non-commissioned and commissioned officer level.

He has established expertise in labour relations. Randy has received numerous awards including the Queens Diamond Jubilee medal for Outstanding Service to Canada (2012), Canada 125 Medal for Outstanding Service to Canada’s First Nations (1994), Canadian Peacekeeping Medal (2000), United Nations Peacekeeping Medal (Kosovo 2000) as well as an RCMP Long Service Medal.

 

Corporate Directory

Corporate Head Office
102-1561 Sutherland Ave
​V1Y 5Y7
Kelowna, B.C
Tel: 1-778-583-4476
Email: info@marapharm.com

 

Auditors

WDM, Chartered Professional Accountants
Suite 420, 1501 West Broadway
Vancouver, BC V6J 4Z6
Tel: 1-604-734-3247

 

Transfer Agents

Computershare Investor Services Inc.
3rd Floor 510 Burrard Street
Vancouver, BC Canada, V6C 3B9
Tel: 1-604-661-9400
Fax: 1-604-661-9480
Investor Services:
Toll Free: 1-800-564-6253
Email: service@computershare.com

Odyssey Trust Agency
United Kingdom Building
835 – 409 Granville Street
Vancouver BC V6C 1T2
Tel: 1-778-819-1184
Email: info@odysseytrust.com

 

Investor Relations

Email: ir@marapharm.com


Legal Counsel

Corporate Counsel
Doak Shirreff Lawyers
200-537 Leon Avenue
Kelowna BC Canada V1Y 2A9

 

Securities Lawyer

McMillan LLP
Royal Centre, Suite 1500
1055 West Georgia Street, PO Box 11117
Vancouver, British Columbia
Canada V6E 4N7
t: 604.689.9111
f: 604.685.7084
e: info@mcmillan.ca

 

FORWARD LOOKING STATEMENT

This page contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the “ACT”). In particular, when used in the preceding discussion, the words “pleased”, “plan”, “confident that”, “believe”, “expect”, and/or “intend to”, and similar conditional expressions are intended to identify forward-looking statements within the meaning of the Act and are subject to the safe harbor created by the Act. Such statements are subject to certain risks and uncertainties and actual results could differ materially from those expressed in any of the forward-looking statements. Such risks and uncertainties include, but are not limited to, market conditions, competitive factors, the ability to successfully complete additional financings and other risks. This document is not an offer to buy or sell securities. Securities may only be offered by private placement subscription agreement.